Dangerous Gain of Function (DGOF)
The U.S. Government Policy for Stopping High-Risk Life Sciences Research(July 20, 2026) adopts a broad, risk-based approach rather than list-based approach. This Policy requires continuous evaluation of ongoing life-sciences research for dangerous gain-of-function (DGOF) and potential DGOF, that could result in significant negative societal consequences. This policy is pursuant to Executive Order 14292, Improving the Safety and Security of Biological Research (May 5, 2025) that superseded implementation of the DURC-PEPP Policy, which will be replaced or revised by November 2026. In addition, the Draft NIH Biosafety Policy for Research Involving Biohazards proposes expanding institutional biosafety oversight and strengthening Institutional Biosafety Committee (IBC) responsibilities for research involving a broad range of biological hazards. While, implementation guidance is still forthcoming, SEBLAB investigators are recommended to review their research for DGOF or that has potential for DGOF. This applies to new grant applications, renewal applications, grant flagged by NIH program officer for DGOF assessment. UAB Biosafety Office/IBC Research Safety Committee highly recommend investigators to amend their IBC project registration for review and DGOF-related risk assessment.
In accordance with this Executive Order, which mandates enhanced oversight of biological research that may involve Dangerous Gain-Of-Function (DGOF) activities, the UAB Biosafety Program developed a broad matrix based on type of risk procedures using risk group. Refer to this matrix here: Link to DGOF
If investigators have questions related to their research that have potential scope of DGOF, please contact biosafety@uab.edu